Welcome to our dedicated page for Materialise SEC filings (Ticker: MTLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Materialise NV files as a foreign private issuer, and its SEC reports document financial results, capital actions, and corporate disclosures for its additive manufacturing software, medical, and manufacturing businesses. Form 6-K reports include quarterly result releases, segment revenue for Materialise Medical, Materialise Software, and Materialise Manufacturing, expense categories such as R&D, sales and marketing, and general and administrative costs, cash balances, and exhibits incorporated by reference into a Form F-3 registration statement.
The company’s filings also cover Belgian-law annual report materials, share buyback program updates, treasury-share holdings, exchange execution details, and share-capital disclosures tied to its Nasdaq ADSs and Euronext-listed ordinary shares.
Materialise NV provides an update on its ongoing share buy-back program of up to EUR 30 million. During the period from 29 June 2026 through 3 July 2026, the company repurchased 9,745 shares at an average price of 6.29 EUR, for a total of 61,341 EUR.
Since the program began on 26 January 2026, Materialise has bought back 1,080,342 shares for 5,271,605 EUR (approximately 6,159,996 USD), representing 1.8% of its total shares outstanding. All purchases were executed on NASDAQ through the central order book, with no cross or block trades.
Materialise NV reports progress on its ongoing share buy-back program of up to EUR 30 million. For the period from 22 June 2026 to 26 June 2026, the company repurchased 72,733 shares on Nasdaq at an average price of 5.91 EUR per share, for a total of 430,128 EUR.
Since the program’s start on 26 January 2026, Materialise has bought back 1,070,597 shares for 5,210,264 EUR (6,090,074 USD), equal to 1.8% of total shares outstanding. Materialise currently holds these 1,070,597 shares as treasury stock. No shares were repurchased through cross or block trades; all were executed via the central order book.
Materialise NV reports progress on its ongoing share buyback program of up to EUR 30 million. Between 15 and 19 June 2026, the company repurchased 46,152 shares on Nasdaq at an average price of EUR 5.82, for a total of EUR 268,514.
Since the program started on 26 January 2026, Materialise has bought back 997,864 shares for EUR 4,780,136 (USD 5,600,936), equal to 1.7% of its total shares outstanding, which it now holds as treasury shares.
Materialise NV reports further progress on its share buy-back program. Between 8 and 12 June 2026, the company repurchased 64,272 shares on Nasdaq at an average price of 5.71 EUR per share, for a total of 366,971 EUR.
Since the program started on 26 January 2026, Materialise has bought back 951,712 shares for 4,511,622 EUR (5,290,396 USD), equal to 1.6% of total shares outstanding. The program allows repurchases of up to 30 million EUR, and Materialise now holds 951,712 of its own shares.
Materialise NV is updating investors on progress under its share buy-back program announced on 30 October 2025. The company has authorized an independent financial intermediary to repurchase up to EUR 30 million of its shares.
Between 1 and 5 June 2026, Materialise bought back 79,318 shares on Nasdaq at an average price of EUR 5.72, for a total of EUR 454,021. No shares were acquired through cross trades or block trades, only via the central order book.
Since the program started on 26 January 2026, Materialise has repurchased 887,440 shares for EUR 4,144,651 (USD 4,866,424), which represents about 1.5% of its total shares outstanding. The company currently holds these 887,440 treasury shares.
Materialise NV reports recent activity under its ongoing share buy-back program. The company repurchased 8,706 shares between 25 and 29 May 2026 at an average price of 5.22 EUR per share, for a total of 45,444 EUR.
The buy-back is conducted under a discretionary mandate granted to an independent financial intermediary for up to 30 million EUR. Since 26 January 2026, Materialise has bought back 808,122 shares for 3,690,630 EUR (4,338,310 USD), representing 1.4% of total shares outstanding, all of which it currently holds.
Materialise NV reports progress on its share buy-back program. During 18–22 May 2026, the company repurchased 50,627 shares at an average price of EUR 4.85, for a total of EUR 245,759 (USD 285,684), via NASDAQ’s central order book.
The buy-back program allows repurchases of up to EUR 30 million under a discretionary mandate granted to an independent financial intermediary. Since the program’s start on 26 January 2026, Materialise has bought back 799,416 shares for EUR 3,645,185 (USD 4,285,431), equal to 1.4% of total shares outstanding, which it now holds as its own shares.
Materialise NV provided an update on its ongoing share buy-back program of up to EUR 30 million. Between 11 and 15 May 2026, the company repurchased 74,816 shares at an average price of 4.77 EUR, for a total of 356,986 EUR.
Since the program began on 26 January 2026, Materialise has bought back 748,789 shares for 3,399,426 EUR (3,999,747 USD), representing about 1.3% of its outstanding shares. All recent purchases were executed on Nasdaq via the central order book, with no cross or block trades.
Materialise NV reports modest top-line growth but weaker earnings for 2025 and sets its annual shareholders’ meeting for 16 June 2026. Consolidated revenue edged up 0.3% to €267.6 million, while net profit fell to €7.7 million from €13.4 million, mainly due to higher financial expenses driven by unfavorable foreign exchange movements.
The Materialise Medical segment was the main growth driver, with revenue rising 15.4% to €134.2 million and an adjusted EBITDA margin of 32.0%. Software revenue declined 6.8% to €40.9 million as the business transitions to cloud and subscription models, although its adjusted EBITDA margin improved to 13.4%. Manufacturing revenue dropped 13.2% to €92.5 million, pushing adjusted EBITDA to a loss of €4.2 million.
On the balance sheet, total assets increased to €420.6 million, equity attributable to owners rose to €255.6 million, and cash and cash equivalents climbed to €133.9 million, alongside higher loans and borrowings of €57.5 million. Management highlights that internal control weaknesses identified in 2024 were fully remediated in 2025 and that disclosure controls and procedures were deemed effective as of 31 December 2025. The group also completed the sale of its RapidFit business assets at carrying value, with no material profit or loss expected.
Materialise NV provides an update on its share buy-back program. The company repurchased 44,893 shares between 4 and 8 May 2026 at an average price of 4.67 EUR, for a total of 209,653 EUR.
Since the program began on 26 January 2026, Materialise has bought back 673,973 shares for 3,042,441 EUR (3,581,452 USD), equal to 1.1% of total shares outstanding. The company currently holds these 673,973 shares and continues to report weekly progress on its investor website.